Abstract
Leukocyte recruitment is one of the most important cellular responses to tissue damage. Leukocyte extravasation is exquisitely regulated by mechanisms of selective leukocyte-endothelium recognition through adhesion proteins in the endothelial cell surface that recognize specific integrins in the activated leukocytes. A similar mechanism is used by tumor cells during metastasis to extravasate and form a secondary tumor. Nitric oxide (NO) has been classically described as an anti-inflammatory molecule that inhibits leukocyte adhesion. However, the evidence available shows also a positive role of NO in leukocyte adhesion. These apparent discrepancies might be explained by the different NO concentrations reached during the inflammatory response, which are highly modulated by the expression of different nitric oxide synthases, along the inflammatory response and by changes in their subcellular locations.
Leukocyte Adhesion and Nitric Oxide (NO)
Inflammation involves the interplay of multiple biologic components, among which endothelial cells are key players. Endothelial cells orchestrate leukocyte transmigration to injured tissues by up-regulating adhesion proteins on their surface to bind integrins in leukocytes (Ley et al., 2007; Fan and Ley, 2015; Kreuger and Phillipson, 2016). Initial contact and rolling steps are initiated by endothelial cell leukocyte adhesion molecule-1 (ELAM-1, E-selectin) and P-selectin, which are expressed in the endothelium and bind to L-selectin, PSGL-1, CD44, CD43, and ESL-1 in the leukocyte. During the rolling phase, the interactions between leukocytes and endothelial selectins reduce leukocyte velocity and facilitate their adhesion to endothelium. Selectin proteins have a high degree of association/dissociation with their leukocyte ligands, which allows contact between the endothelial cell and leukocytes and provides enough time and proximity for other adhesion molecules to establish strong bonds between both cells (Sperandio, 2006; Garrido-Urbani et al., 2008; Tvaroška et al., 2020). Firm leukocyte adhesion to endothelial cells is mediated by vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) that bind to leukocytes integrin’s VLA-4, LFA-1, and Mac-1 (Greenwood et al., 2003). Once the leukocytes are attached to the endothelium, they flatten by contacting the endothelium at varying distances, probably to reduce their exposure to blood flow forces and collisions with circulating blood cells, and subsequently they initiate their trans-endothelial migration (Ley et al., 2007; Leick et al., 2014).
Nitric oxide (NO) is a physiological messenger that regulates many cellular functions, such as vasodilation, angiogenesis, vascular permeability, neurotransmission, cell migration, immune response, cell proliferation and apoptosis (Tuteja et al., 2004; Nagy et al., 2007; Koriyama and Furukawa, 2018; Ehrenfeld et al., 2019; López-Sánchez et al., 2019). NO is produced in the organism by three different nitric oxide synthases: endothelial (eNOS, mainly expressed in endothelium), inducible (iNOS, expressed primarily on the immune system and endothelial cells) and neuronal (nNOS, expressed in the nervous system) (Förstermann and Sessa, 2012). NO produced by these isoforms activates two main signaling pathways: (1) soluble guanylate cyclase – protein kinase G (GC1-PKG) and (2) S-nitrosylation, which is the modification induced by NO in free-thiol cysteines in proteins to form S-nitrosothiols. S-nitrosylation regulates interactions between proteins, phosphorylation and intracellular trafficking (Stamler et al., 1992; Huang et al., 2005; Marín et al., 2012; Guequén et al., 2016).
The first studies addressing the role of NO in leukocyte adhesion used different inhibitors of NO production like L-NG-monomethyl arginine (L-NMMA) or N omega-Nitro-L-arginine methyl ester (L-NAME) to observe the effect on the basal leukocyte adhesion (in the absence of inflammatory stimulation). These experiments showed an increased basal leukocyte adhesion in vivo in different animal preparations and endothelial cell cultures in vitro (Kubes et al., 1991; Arndt et al., 1993; Ma et al., 1993; Tsao et al., 1994). The opposite approach, to elevate the NO concentration by the use of NO donors, prevented leukocyte adhesion and infiltration depending on NO level (Johnson et al., 1990; Kubes et al., 1991; Kubes and Granger, 1992). Studies using intravital microscopy in knockout (KO) animals for eNOS and nNOS corroborated these results showing increased leukocyte adhesion relative to control animals in the mesentery (Lefer et al., 1999). These observations and those from other laboratories led to the well-established concept that, in healthy endothelium, there is a physiological constitutive level of NO produced by eNOS that confers anti-adhesive and anti-inflammatory properties to the endothelial cell membrane and plays a critical role in preventing leukocyte adhesion (Kubes et al., 1991; Tsao et al., 1994). On the other hand, when the endothelium is stimulated with pro-inflammatory agonist, the effects of NO have not been completely consistent. There is a vast body of evidence showing an inhibitory effect of NO on stimulated leukocyte adhesion (De Caterina et al., 1995; Liu et al., 1998; Baatz and Pleyer, 2001; Lelamali et al., 2001; Lo et al., 2001; Jiang et al., 2005; Shelton et al., 2008); while other reports demonstrate either no effect of inhibition of NO on leukocyte adhesion (Hickey et al., 2001; Shelton et al., 2008) or promotion – mediated by NO – of leukocyte adhesion in response to challenge with cytokines (Bessa et al., 2002; Joussen et al., 2002). These discrepancies may be due to several differences in experimental approaches including timing and duration of the application of agonist/antagonist. We review here how NO regulates leukocyte adhesion by acting on different mechanisms that regulate surface expression of adhesion proteins on the endothelium such as: (a) through transcriptional regulation; (b) through non-transcriptional regulation, including traffic of vesicles to plasma membrane and clustering of adhesion proteins normally expressed in the endothelium. NO can also regulates integrin and protein expression and/or affinity on leukocytes (Kubes et al., 1991; Banick et al., 1997; Mitchell et al., 1998; Thom et al., 2013; Bhopale et al., 2015); however, given the enormous big of data on the topic, this review will focus only in the NO effects on the adhesion protein expression on the endothelium.
Transcriptional Regulation of Adhesion Proteins and NO
The effects of NO on leukocyte adhesion are related to transcriptional regulation of adhesion proteins expression on the endothelium (De Caterina et al., 1995; Khan et al., 1996; Liu et al., 1998; Lefer et al., 1999; Waldow et al., 2006; Buckanovich et al., 2008; Carreau et al., 2011; Stojak et al., 2018). Transcriptional regulation adhesion proteins, as well as numerous proinflammatory genes, is under the control of NF-κB (Springer, 1990; Collins et al., 1995; Ledebur and Parks, 1995; Pierce et al., 1997; Qian and Fulton, 2012), a dimeric protein formed by any of the members of the Rel family (p50, p65 or Rel-A, p52, c-Rel, and RelB) (Thanos and Maniatis, 1995; Marshall and Stamler, 2001). The classic form of NF-κB is the p50–p65 heterodimer that is kept inactive in the cytosol via interaction with the inhibitory protein IKBα (Thanos and Maniatis, 1995; Marshall and Stamler, 2001; Hayden and Ghosh, 2008; Sha and Marshall, 2012). Activation of cytokine receptors promotes the phosphorylation, ubiquitination, and proteasomal degradation of IKBα mediated by the IKKβ subunit of the IKK complex, formed by IKKα, β, and γ, which results in translocation of the p50–p65 heterodimer to the nucleus to bind target DNA sites, and activate gene transcription (Marshall and Stamler, 2001; Hayden and Ghosh, 2008; Sha and Marshall, 2012; Figure 1). Activation of the NF-κB pathway leads to de novo synthesis of high levels of messenger RNA for E-selectin, P-selectin, ICAM-1, and VCAM-1, which induces an increase in protein expression of these proteins in activated endothelial cells, and enhances the adhesion of leukocytes on the cell surface (Whelan et al., 1991; Iademarco et al., 1992; Van De Stolpe et al., 1994; Pan and McEver, 1995; Xia et al., 2001; Mussbacher et al., 2019).
FIGURE 1
Mechanism of NF-kB activation. Proinflammatory stimulation leads to the phosphorylation of IKKβ leading to phosphorylation of IKBα in NF-κB. This phosphorylation result in the ubiquitination and degradation of IκB-α in the proteasome. At this moment, the dimer p50–p65 enters into the nucleus, binds to the targets gene promoter (κB sites), and activates transcription.
Early investigations demonstrated that inhibition of NO production activated NF-κB and protein adhesion expression, whereas NO donors had the opposite effect (De Caterina et al., 1995; Khan et al., 1995). These effects were not mediated by the GC1-PKG pathway and appeared to depend strictly on NO concentration, suggesting that S-nitrosylation might be the operating mechanism (De Caterina et al., 1995; Lee et al., 2002; Waldow et al., 2006). Later, it was demonstrated that there is a basal S-nitrosylation of IKKβ that prevents IKBα phosphorylation and degradation, keeping NF-κB inactive (Figure 2A; Reynaert et al., 2004). Basal S-nitrosylation of p65 has also been reported in respiratory epithelium (A549 cells) and lung tissue (Kelleher et al., 2007, 2011). Inhibition of NOS activity reduced nitrosylation of IKKβ, leading to NF-κB activation in Jurkat T cells (Reynaert et al., 2004). Even though the role of basal S-nitrosylation has not been investigated, studies using cytokine-stimulated cells indicate that S-nitrosylation of p65 blocks the binding of NF-κB to DNA (Kelleher et al., 2007, 2011). Therefore, it is possible that basal S-nitrosylation of p65 contributes to keeping NF-κB inactivated. We postulate that the dynamics of S-nitrosylation cellular levels may be key to activation/inactivation of NF-κB.
FIGURE 2
NF-κB is regulated by S-nitrosylation. (A) Basal conditions: basal S-nitrosylation of IKKβ and p65 blocks IKBα phosphorylation and degradation proteasomal and the entry of the dimer p50–p65 to the nucleus, keeping NF-κB inactivated. (B) Short inflammatory stimulation: under stimulation, there is a decrease in the S-nitrosylation levels of IKKβ and p65 favoring IKBα phosphorylation and proteasomal degradation and the consequent entry of the dimer p50–p65 to the nucleus to increase adhesion protein transcription among others. (C) Long stimulation: at long periods of exposure to proinflammatory agents, high levels of NO-produced by iNOS induces S-nitrosylation of p65 and p50, which inhibit the binding of the dimer to the DNA. IKKβ might also be S-nitrosylated contributing to inactivate NF-κB.
After short inflammatory stimulation (10 min–2 h) with TNF-α or LPS, the S-nitrosylation levels of IKKβ and p65 decrease and NF-κB is activated (Reynaert et al., 2004; Kelleher et al., 2011, 2014; Figure 2B). At long times of exposure (6h, LPS), p65 is S-nitrosylated again with the consequent NF-κB inactivation (Kelleher et al., 2007, 2011). Studies using iNOS KO mice revealed that the high levels of NO-induced by this enzyme mediated this effect since genetic deletion of iNOS in mice blocks the recovery of S-nitrosylation of p65, and NF-κB activation is maintained along with prolonged inflammation in a model of LPS-induced lung inflammation (Kelleher et al., 2011). In addition, in a colitis model in iNOS KO mice, inflammation and elevated MPO activities persisted at 2 weeks compared to control mice, which improved colitis and decreased MPO activity (Vallance et al., 2004). iNOS also mediates S-nitrosylation of p50, which contributes to inhibiting NF-κB DNA binding (Matthews et al., 1996; DelaTorre et al., 1998; Marshall and Stamler, 2001). Even though it has not been reported, the high levels of NO-induced by iNOS might also re-nitrosylate IKKβ contributing to NF-κB inactivation (Figure 2C).
Although the evidence described above strongly points to a physiological role for iNOS in the inactivation of NF-κB, other report demonstrated that higher concentrations of NO – beyond those reached by iNOS expression – are required for NF-κB inactivation by S-nitrosylation of IKKβ and p65 (Qian and Fulton, 2012). It is important, however, to note that the report by Qian and Fulton used endothelial cells transfected with iNOS and not physiological iNOS induction by stimulation with pro-inflammatory cytokines.
In strong contrast to the results described above, other investigations demonstrated that inhibition of NO production did not increase adhesion protein expression induced by cytokines or leukocyte adhesion to endothelial monolayers (De Caterina et al., 1995). Furthermore, some reports have demonstrated that NO promotes protein adhesion expression. In diabetic rats, a high retinal leukocyte adhesion was observed, which correlated with a rise in NO and ICAM-1 levels. Pharmacological inhibition of NOS with L-NAME also reduces leukocyte adhesion (Joussen et al., 2002). In human vascular aortic smooth muscle cells (HASMCs), LPS treatment by 24 h increased ICAM-1 expression. Inhibition of NOS with L-NAME, prior to LPS administration, inhibited this effect, demonstrating that NO is required for enhancing ICAM-1 expression under this experimental conditions (Heo et al., 2008). In addition, the stimulation of rat microvascular endothelial cells with VEGF, that activates eNOS, increased ICAM-1 expression in 30 min, suggesting that eNOS regulates ICAM-1 transcription (Radisavljevic et al., 2000). The fact that eNOS is involved suggests that low NO concentrations but higher than basal might stimulate adhesion protein transcription. In fact, in HUVECs cells, NO donors increased ICAM-1, VCAM-1, and ELAM-1 expression. This effect was dependent on the NO donor concentrations used, with low concentrations (10 and 50 μM) inducing adhesion protein expression, whereas higher levels (250 and 500 μM) did not cause protein adhesion expression (Sektioglu et al., 2016). Microarray analysis of HUVEC treated with NO donors at low concentration or TNF-α demonstrated that 473 genes were upregulated, including VCAM-1 and E-selectin. The effect of NO donor on protein adhesion expression was dependent on NF-κB activation, because the effect was blocked by the NF-κB inhibitor BAY11-7082. These results coincide with earlier studies demonstrating that low NO concentration improved NF-κB activity induced by TNF-α, whereas higher concentrations inhibited NF-κB activity (Umansky et al., 1998). These low NO doses (but still higher than basal), might be achieved by eNOS activation, as many pro-inflammatory agents induce rapid eNOS activation (Marín et al., 2012; Guequén et al., 2016). The precise mechanism by which exogenous administration of low concentrations of NO activate NF-κB dependent protein adhesion expression in endothelial cells remains to be explored. A possible explanation could be given by the changes in eNOS localization under inflammatory stimulation (Figure 3). In non-stimulated cells, basal NO production generated by eNOS (located in the Golgi and caveolae) (Feron and Balligand, 2006; Zhang et al., 2006) maintains an anti-adhesive phenotype through basal S-nitrosylation of IKKβ and p65 (Matsushita et al., 2003; Feron and Balligand, 2006; Zhang et al., 2006). Under short-time stimulated conditions, eNOS is activated and change its localization (Sánchez et al., 2006, 2011; Marín et al., 2012), which might reduce S-nitrosylation of IKKβ and p65 activating NF-κB. Additionally, eNOS-induced NO might activate protein adhesion expression by mechanisms still unknown. At extended times of inflammatory stimulation, the high levels of NO induced by iNOS activation will inhibit NF-κB by enhancing S-nitrosylation of IKKβ, p65 and additional S-nitrosylation of p50. Thus, low concentrations of NO achieved by eNOS activation and short exposure times to agonists increase adhesion protein expression, whereas higher NO concentrations achieved by iNOS stimulation and longer times of stimulation will inhibit protein adhesion expression (Umansky et al., 1998; Sektioglu et al., 2016).
FIGURE 3
Changes in eNOS localization under short inflammatory stimulation can activate NF-κB. In unstimulated cells, the basal production of NO generated by eNOS (located at the Golgi and caveolae) provides basal S nitrosylation of IKKβ and p65 to maintain an anti-adhesive phenotype (left pannel). Under short-term proinflammatory conditions, eNOS is activated and changes in its location might decrease NO levels around IKKβ and p65, decreasing their S-nitrosylation levels leading to NF-κB activation (right pannel).
Non-transcriptional Regulation of Adhesion Proteins and NO
Many pro-inflammatory agents induce a fast leukocyte adhesion observed within minutes of exposure to some pro-inflammatory agents (Dillon et al., 1988; Sugama et al., 1992; Javaid et al., 2003) that cannot be explained by transcriptional regulation. This fast adhesion may be explained by mechanisms such as vesicle traffic and clustering (Javaid et al., 2003; Ley et al., 2007; Lowenstein, 2007; Barreiro et al., 2008; Setiadi and McEver, 2008; Liu et al., 2011).
Vesicle Traffic
Adhesion proteins are stored in vesicles in endothelial cells that are transported to the plasma membrane after inflammatory stimulation. ELAM-1, for instance, is stored in intracellular secretory granules of endothelial cells and is rapidly expressed on the cell surface following degranulation, within minutes of exposure to activating agents such as thrombin, histamine, or phorbol esters (Geng et al., 1990; Larsen et al., 1992). The same is true for P-selectin, which is usually stored in Weibel-Palade bodies (WPB) (Weibel and Palade, 1964; Metcalf et al., 2008). In the case of VCAM-1, evidence indicates that after TNF-α treatment of endothelial cells, vesicular transport from an intracellular pool to the cell surface is increased (MacKesy and Goalstone, 2011).
Clustering
In basal conditions without inflammatory stimulation, low levels of adhesion proteins are present in an inactive state in the endothelial plasma membrane (Barreiro et al., 2002, 2008; Javaid et al., 2003). The lateral association of adhesion proteins, a process known as clustering, also regulates their adhesive capacity (Javaid et al., 2003; Barreiro et al., 2008; Setiadi and McEver, 2008; Liu et al., 2011). Through clustering, cell surface expression of adhesion proteins does not change; instead, they are regrouped and interact with cytoskeletal proteins to increase their avidity for leukocyte integrins (Javaid et al., 2003; Liu et al., 2011). This affinity change process occurs at short times of stimulation (minutes) and allows a fast response under inflammatory stimulation. In the case of ELAM-1, clustering is promoted by association to lipid rafts and caveolae at the plasma membrane (Tilghman and Hoover, 2002a,b; Setiadi and McEver, 2008). P-selectin clustering is mediated by interactions of the cytoplasmic domain of P-selectin with clathrin-coated pits (Setiadi et al., 1998). Clustering of ICAM-1 and VCAM-1 is promoted by association with tetraspanins, which are small transmembrane proteins able to associate laterally with different proteins at the plasma membrane (Barreiro et al., 2008). ICAM-1 clustering is also regulated by protein kinase C zeta (PKCz), that under stimulation with TNF-α, is activated and translocated to the plasma membrane to phosphorylate ICAM-1 either directly or through Src activation (Javaid et al., 2003; Liu et al., 2011).
NO Role in Vesicle Transport and Clustering
Many reports have demonstrated a NO role in anterograde and retrograde transport (Iwakiri et al., 2006; Lowenstein, 2007; Lee et al., 2009; Marín et al., 2012). N-ethylmaleimide sensible factor (NSF) is an ATPase that modulates vesicular transport (Söllner et al., 1993; Morgan and Burgoyne, 2004) and studies in vitro and in vivo have shown that there is a basal NSF-S-nitrosylation mediated by eNOS that inhibits the translocation of WPB containing P-selectin to the plasma membrane contributing to the anti-adhesive properties of basal NO production in the endothelium (Matsushita et al., 2003; Lowenstein, 2007). Basal eNOS activity also contributes to the anti-adhesive properties of the endothelium by inhibiting ICAM-1 clustering as it has been demonstrated that eNOS inhibition led to ICAM-1 clustering mediated by Src phosphorylation in endothelial cells in vitro and in vivo (Xu et al., 2013; Gao et al., 2018). These observations can account for the fast leukocyte adhesion observed when basal NO production is inhibited in the absence of inflammatory stimulation (Kubes et al., 1991; Ma et al., 1993; Gao et al., 2018) but do not explain the fast leukocyte adhesion observed under inflammatory stimulation (Dillon et al., 1988; Sugama et al., 1992; Javaid et al., 2003). Changes in eNOS localization might again explain this effect. In non-stimulated cells, basal NO production generated by eNOS located to the Golgi and caveolae (Feron and Balligand, 2006; Zhang et al., 2006) will maintain an anti-adhesive phenotype in part by basal S-nitrosylation of NSF and also by inhibiting ICAM-1 clustering (Feron and Balligand, 2006; Zhang et al., 2006; Lowenstein, 2007; Mukhopadhyay et al., 2008; Gao et al., 2018; Figure 4A). In fact, only wild type eNOS (located at Golgi and caveolae) induce NSF-S-nitrosylation and inhibit vesicular transport but not eNOS located at the nucleus (Iwakiri et al., 2006). Furthermore the treatment of endothelial cells with monocrotaline pyrrole (MCPT), a drug that blocks the association of NSF with eNOS at Golgi and prevents eNOS localization in caveolae inhibits NSF-S-nitrosylation (Mukhopadhyay et al., 2008; Lee et al., 2009). After short inflammatory stimulation, eNOS redistribution from caveolae and Golgi to cytosol (Sánchez et al., 2006, 2011; Marín et al., 2012), might reduce S-nitrosylation of NSF, to stimulate the release of WPB bodies (Figure 4B). At the same time, the change in eNOS localization might also diminish NO levels close to ICAM-1 in the plasma membrane to stimulate ICAM-1 clustering. On the other hand, the movement of eNOS to different subcellular locations will increase NO levels at those locations, which may actively stimulate traffic of vesicles, stimulating for instance the formation of complexes that promote transport to the cell surface such as VAMP/SNAP-25/syntaxin-1a and/or VAMP-3/syntaxin-2 that have been demonstrated to be stimulated by NO and promote synaptic vesicle exocytosis and release of secretory granules in neurons and platelets, respectively (Meffert et al., 1996; Randriamboavonjy et al., 2004; Figure 4C). Interestingly, NSF-S-nitrosylation has also been reported to stimulate protein transport to the cell surface of AMPA receptors and VSVG protein in neurons and epithelial cells, respectively (Huang et al., 2005; Iwakiri et al., 2006) unlike its inhibitory role in endothelial cells. Considering that NSF has 8 cysteines that can be S-nitrosylated (Matsushita et al., 2003), it is possible that different degrees of S-nitrosylation may also play a role in transport to the plasma membrane. Basal S-nitrosylation of NSF will inhibit transport, whereas decrease or elevation in S-nitrosylation might stimulate traffic. Besides traffic, an elevation in NO, might also stimulate ICAM-1 clustering since Src that promote ICAM-1 phosphorylation is activated by S-nitrosylation in another cellular context (Rahman et al., 2010). PKCζ, that also participate in ICAM-1 clustering (Javaid et al., 2003; Matsushita et al., 2003; Liu et al., 2011) might be also activated by NO and S-nitrosylation since N-ethylmaleimide that blocks the thiol groups decreases the activity of PKCζ (Kikkawa et al., 1987) and a PKCζ synthetic peptide containing the activation site is S-nitrosylated in vitro (Balendran et al., 2000; Wang et al., 2008).
FIGURE 4
Proposed mechanism of NO role in the fast leukocyte adhesion. (A) In unstimulated cells, the basal NO production generated by eNOS located to the Golgi and caveolae maintain an anti-adhesive state in the endothelium by basal NSF-S-nitrosylation that inhibits the translocation of vesicles containing adhesion molecules to the plasma membrane and by blocking the clustering of adhesion molecules like ICAM-1. (B) After short inflammatory stimulation, eNOS redistribution, might put NO away from NSF, diminishing NSF-S-nitrosylation to stimulate the transport of vesicles to the plasma membrane. At the same time, the change in eNOS localization might also lower NO levels close to ICAM-1 to promote ICAM-1 clustering. (C) At the same time, the movement of eNOS to different subcellular locations will increase NO levels at those locations, which may active the SNAREs complexes (VAMP, SNAP25, and syntaxin) stimulating traffic of vesicles; NO can also induce S-nitrosylation of Src and PKCz to promote ICAM-1 phosphorylation and clustering.
Thus, the combined effects of releasing the inhibition induced by basal NO on vesicular transport and clustering, plus the active stimulation by NO of pathways that increase vesicular transport and clustering, will induce leukocyte adhesion at short times of simulation.
No and Tumor Cell Adhesion
There is considerable evidence demonstrating a dual role of NO and S-nitrosylation in cancer risk and metastasis (Burke et al., 2017; Rizza and Filomeni, 2018; Ehrenfeld et al., 2019; Hays and Bonavida, 2019; Holotiuk et al., 2019; Somasundaram et al., 2019). The available evidence demonstrates a positive correlation between NO biosynthesis, tumor development and degree of malignancy in a variety of cancers (breast, pancreatic, liver, cervical, ovary, melanoma, nasopharyngeal, stomach, colon, lung, oral, esophagus, glioma, and prostate cancer) (Monteiro et al., 2015; Vanini et al., 2015; Burke et al., 2017; Thomas and Wink, 2017; Somasundaram et al., 2019). On the other hand, in animal studies, inhibition or genetic deletion of eNOS or iNOS can inhibit, have no effect, or even increase primary tumor growth and metastasis depending on the type of cancer (Wang et al., 2001, 2003; Gratton et al., 2003; Heinecke et al., 2014; Granados-Principal et al., 2015; McCrudden et al., 2017; Kij et al., 2018; Romagny et al., 2018; Flaherty et al., 2019). These discrepancies probably reflect the fact that NO effects strongly depend on its concentration, duration of exposure, location and activity of NOS isoforms, tumor type, its microenvironment and sensitivity to NO (Ridnour et al., 2006; López-Sánchez et al., 2019; Somasundaram et al., 2019). In the tumoral microenvironment, tumor cells express iNOS, eNOS, and nNOS, depending on tumor type and stage, endothelial cells express eNOS and iNOS whereas tumor-associated stromal fibroblasts and immune cells express iNOS (Fukumura et al., 2006; Monteiro et al., 2015; López-Sánchez et al., 2019). Therefore, the results can be conflicting depending on the experimental set-up and the cell type being investigated.
Despite remarkable developments in cancer therapeutics, metastasis is still closely associated with high mortality rates in cancer patients. Metastasis occurs when tumor cells separate from the primary tumor, enter the bloodstream (or lymph) and travel to remote organs to form a secondary tumor. One of the final events in metastasis is the extravasation of cancer cells across the endothelial barrier (Talmadge, 2010; Sökeland and Schumacher, 2019). Cytokines and other factors produced by the primary tumor, circulating tumor cells and cells in the metastatic microenvironment promote binding between tumor cells and endothelial cells (Wolf et al., 2012; Reymond et al., 2013; Strilic and Offermanns, 2017). Initial insights into tumor cell extravasation were derived from studies of leukocyte extravasation, resulting in the widely accepted concept that cancer cell and leukocyte extravasation – although different – share many similarities (Strell and Entschladen, 2008; McDowell and Quail, 2019; Sökeland and Schumacher, 2019). Increased cell surface expression of adhesion proteins ELAM-1, ICAM-1, VCAM-1, and P-selectin in the endothelium mediate direct adhesion to CD44, mucin-1 and CD24 in breast tumor cells (Aigner et al., 1998; Rahn et al., 2005; Geng et al., 2012; Shirure et al., 2015). Alternatively, tumor cells can bind to macrophages, neutrophils or platelets in the circulation and these cells mediate the adhesion of tumor cells to the endothelium acting as a bridge among tumor and endothelial cells (Evani et al., 2013; Reymond et al., 2013).
The evidence strongly suggests an stimulatory role of NO in tumor cell adhesion: NOS inhibitors blocked small cell lung carcinoma adhesion to the endothelium treated with pro-inflammatory cytokines (Vidal et al., 1992). NO enhanced fibrosarcoma cell adhesion and invasion through HUVEC monolayers, increasing ICAM-1 and ELAM-1 expression (Yudoh et al., 1997). In vivo, NO caused squamous carcinoma cell binding to the hepatic microcirculation (Scher, 2007). Breast circulating tumor cells MDA-MB-231 adhered to endothelial sites with high NO concentration (Zhang et al., 2016). Rhus coriaria, a medicinal plant that in part inhibits NO pathway decreases the adhesion and transmigration of MDA-MB-231 cells to endothelial cells activated with TNF-α (El Hasasna et al., 2016). The mechanisms that increase tumor cell adhesion to endothelium have not been studied in detail but are probably the same already described for leukocyte adhesion involving NF-κB transcriptional regulation, traffic and clustering of adhesion proteins. Additionally, another transcription factor, HIF-1α expressed in endothelial cells, is involved in extravasation of breast cancer cells through the expression of L1CAM adhesion protein that binds to tumor cells, and HIF-1α has been demonstrated to be activated by S-nitrosylation in others cellular contexts (Li et al., 2007; Zhang et al., 2012; Ehrenfeld et al., 2019).
As in leukocyte adhesion to endothelium, NO also shows a negative role in tumor cell adhesion: exogenously applied and endogenously generated NO inhibit melanoma cells adhesion to endothelium activated with lipopolysaccharide (Kong et al., 1996). The NO donor, CAP-NO, inhibited the basal and cytokine-stimulated adhesion of human colorectal cancer cells HT-29 to endothelial cells by inhibiting the expression of adhesion proteins ELAM-1, ICAM-1, and particularly VCAM-1 (Lu et al., 2014). NO donors inhibits the adhesion of MDA-MB231 cells to HUVEC stimulated by IL-1β and the transmigration of breast cancer cells across the lung microvascular endothelium (Kang et al., 2018; Stojak et al., 2018). This effect was mediated by a decrease in ICAM-1 expression. Similar to leukocyte adhesion, the differential effect of NO on tumor cell adhesion might depend on NO concentrations with low concentrations of NO increasing adhesion protein expression and adhesion of tumor cells, whereas higher NO concentrations, inhibiting protein adhesion expression and tumor cell adhesion (Sektioglu et al., 2016).
The effects of NO on adhesion protein expression not only affect tumor cell adhesion at the metastatic site but also infiltration of immune cells in the primary tumor, where it has been demonstrated that NO, produced by iNOS in M1 macrophages, mediates VCAM-1 expression in the endothelium leading to an improved infiltration of T-lymphocytes specific for the tumor, contributing to decrease tumor growth in a mouse melanoma model (Sektioglu et al., 2016).
After binding to tumor cells, adhesion proteins through their cytosolic tails interact with cytoskeletal proteins inducing changes in the shape of endothelial cells leading to destabilization of the endothelial barrier that facilitates tumor cell transmigration (Müller et al., 2001; Tichet et al., 2015). We have demonstrated that treatment of endothelial cells with conditioned medium from breast cancer cells and cytokines that are elevated in breast cancer patients induces S-nitrosylation of endothelial barrier proteins (p120, VE-cadherin and β-catenin) promoting phosphorylation and perturbation of the interactions among these proteins that leads to their internalization, which destabilizes the endothelial barrier (Marín et al., 2012; Guequén et al., 2016; Zamorano et al., 2019). Thus, better knowledge and understanding of NO biology in cancer is of paramount importance because it regulates not only expression of adhesion proteins that promote metastasis, but also controls the endothelial barrier to promote transmigration of tumor cells and metastasis.
Conclusion
The role of NO in leukocyte adhesion to endothelium has been controversial. Whether NO enhances or inhibits leukocyte adhesion depends on local NO concentration. It is reasonable to state that, in non-stimulated cells, NO concentration maintains an anti-adhesive phenotype at the endothelial cell membrane – inasmuch as inhibition of NOS causes increased leukocyte adhesion. This NO produced by eNOS prevents transport of vesicles to the cell surface, clustering of adhesion proteins and transcription of adhesion proteins by keeping NF-κB in an inactive state. However, an increase in eNOS-derived NO concentration to levels slightly above control is compatible with leukocyte adhesion through increasing cell surface transport, clustering of adhesion proteins and transcription of adhesion proteins via NF-κB activation. In addition, high NO concentration – most likely achieved through stimulation of iNOS – inhibits leukocyte adhesion due to S-nitrosylation of p50 and p65 in NF-κB and presumably IKKβ, which blocks entry of NF-κB to the nucleus leading to inhibition of adhesion protein synthesis. Similar to leukocyte-endothelium adhesion, NO also regulates tumor cell adhesion to endothelium probably through the stimulation of the same mechanisms described above as well as opening of the endothelial barrier, all of which enhance tumor cell extravasation and metastasis (Figure 5).
FIGURE 5
Role of NO in leukocyte and tumor cell adhesion. (A) Basal NO production produced by eNOS located to the Golgi and caveolae maintaining an anti-adhesive phenotype by inhibiting NF-κB activation, traffic of vesicles and clustering of adhesion proteins. (B) At short times of stimulation movement of eNOS away from Golgi and caveolae release the inhibition caused by NO to stimulate NF-κB activation and transcription of adhesion proteins, traffic of vesicles that contain adhesion proteins and clustering. At the same time, the rise in NO concentration in other subcellular locations may induce active mechanisms of adhesion such as formation of SNAREs complexes that stimulate vesicle traffic to the plasma membrane or to stimulate S-nitrosylation of targets such as Src and PKCz that induce clustering of adhesion proteins stimulating leukocyte and tumor cell adhesion. (C) At long times of stimulation, the high NO concentration induced by iNOS activation induce S-nitrosylation of NF-κB and NSF inhibiting the transcription of adhesion proteins and the vesicle transport of adhesion proteins to the plasma membrane.
Statements
Author contributions
GA and TK collaborated in review literature and figures confection. PE collaborated in writing the manuscript and review literature. FS reviewed literature, wrote the manuscript, and reviewed figures. All authors contributed to the article and approved the submitted version.
Funding
Fondecyt grant 1201635 and Vicerrectoría de Investigación, Desarrollo y Creación Artística from Universidad Austral de Chile for its continuous support.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AignerS.RamosC. L.Hafezi-MoghadamA.LawrenceM. B.FriederichsJ.AltevogtP.et al (1998). CD24 mediates rolling of breast carcinoma cells on P-selectin.FASEB J.121241–1251. 10.1096/fasebj.12.12.1241
2
ArndtH.RussellJ. B.KuroseI.KubesP.GrangerD. N. (1993). Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis.Gastroenterology105675–680. 10.1016/0016-5085(93)90882-D
3
BaatzH.PleyerU. (2001). Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects on leukocyte adhesion in endotoxin-induced uveitis.Inflamm. Res.50534–543. 10.1007/PL00000231
4
BalendranA.BiondiR. M.CheungP. C. F.CasamayorA.DeakM.AlessiD. R. (2000). A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC- related kinase 2 by PDK1.J. Biol. Chem.27520806–20813. 10.1074/jbc.M000421200
5
BanickP. D.ChenQ.XuY. A.ThomS. R. (1997). Nitric oxide inhibits neutrophil B2 integrin function by inhibiting membrane-associated cyclic GMP synthesis.J. Cell Physiol.17212–24. 10.1002/(sici)1097-4652(199707)172:1<12::aid-jcp2>3.0.co;2-g
6
BarreiroO.Yáñez-MóM.SerradorJ. M.MontoyaM. C.Vicente-ManzanaresM.TejedorR.et al (2002). Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.J. Cell Biol.1571233–1245. 10.1083/jcb.200112126
7
BarreiroO.ZamaiM.Yáñez-MóM.TejeraE.López-RomeroP.MonkP. N.et al (2008). Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms.J. Cell Biol.183527–542. 10.1083/jcb.200805076
8
BessaX.ElizaldeJ. I.MitjansF.PiolV.MiquelR.PanésJ.et al (2002). Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor β1.Gastroenterology1221122–1132. 10.1053/gast.2002.32369
9
BhopaleV. M.YangM.YuK.ThomS. R. (2015). Factors associated with nitric oxide-mediated β2 integrin inhibition of neutrophils.J. Biol. Chem.29017474–17484. 10.1074/jbc.M115.651620
10
BuckanovichR. J.FacciabeneA.KimS.BenenciaF.SasaroliD.BalintK.et al (2008). Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.Nat. Med.1428–36. 10.1038/nm1699
11
BurkeA. J.GarridoP.JohnsonC.SullivanF. J.GlynnS. A. (2017). Inflammation and nitrosative stress effects in ovarian and prostate pathology and carcinogenesis.Antioxidants Redox Signal.261078–1090. 10.1089/ars.2017.7004
12
CarreauA.KiedaC.GrillonC. (2011). Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment.Exp. Cell Res.31729–41. 10.1016/j.yexcr.2010.08.011
13
CollinsT.ReadM. A.NeishA. S.WhitleyM. Z.ThanosD.ManiatisT. (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers.FASEB J.9899–909. 10.1096/fasebj.9.10.7542214
14
De CaterinaR.LibbyP.PengH. B.ThannickalV. J.RajavashisthT. B.GimbroneM. A.et al (1995). Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.J. Clin. Invest.9660–68. 10.1172/JCI118074
15
DelaTorreA.SchroederR. A.BartlettS. T.KuoP. C.BuchmanT. G.WeigelR. J.et al (1998). Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding.Surgery124137–142. 10.1016/S0039-6060(98)70113-8
16
DillonP. K.FitzpatrickM. F.RitterA. B.DuránW. N. (1988). Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium, time course and dose-response relationships.Inflammation12563–573. 10.1007/BF00914318
17
EhrenfeldP.CordovaF.DuranW. N.SanchezF. A. (2019). S-nitrosylation and its role in breast cancer angiogenesis and metastasis.Nitric Oxide Biol. Chem.8752–59. 10.1016/j.niox.2019.03.002
18
El HasasnaH.SalehA.SamriH. A.AthamnehK.AttoubS.ArafatK.et al (2016). Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3. NFΰ B and nitric oxide pathways.Sci. Rep.61–15. 10.1038/srep21144
19
EvaniS. J.PrabhuR. G.GnanarubanV.FinolE. A.RamasubramanianA. K. (2013). Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow.FASEB J.273017–3029. 10.1096/fj.12-224824
20
FanZ.LeyK. (2015). Leukocyte arrest: biomechanics and molecular mechanisms of β2 integrin activation.Biorheology52353–377. 10.3233/BIR-15085
21
FeronO.BalligandJ. L. (2006). Caveolins and the regulation of endothelial nitric oxide synthase in the heart.Cardiovasc. Res.69788–797. 10.1016/j.cardiores.2005.12.014
22
FlahertyR. L.IntabliH.FalcinelliM.BuccaG.HeskethA.PatelB. A.et al (2019). Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase.Cancer Lett.45959–71. 10.1016/j.canlet.2019.05.027
23
FörstermannU.SessaW. C. (2012). Nitric oxide synthases: regulation and function.Eur. Heart J.33829–837. 10.1093/eurheartj/ehr304
24
FukumuraD.KashiwagiS.JainR. K. (2006). The role of nitric oxide in tumour progression.Nat. Rev. Cancer6521–534. 10.1038/nrc1910
25
GaoF.Lucke-WoldB. P.LiX.LogsdonA. F.XuL. C.XuS.et al (2018). Reduction of endothelial nitric oxide increases the adhesiveness of constitutive endothelial membrane ICAM-1 through Src-mediated phosphorylation.Front. Physiol.8:1124. 10.3389/fphys.2017.01124
26
Garrido-UrbaniS.BradfieldP. F.LeeB. P. L.ImhofB. A. (2008). Vascular and epithelial junctions: a barrier for leucocyte migration.Biochem. Soc. Trans.36203–211. 10.1042/BST0360203
27
GengJ. G.BevilacquatM. P.MooreK. L.McIntyreT. M.PrescottS. M.KimJ. M.et al (1990). Rapid neutrophil adhesion to activated endothelium mediated by GMP-140.Nature343757–760. 10.1038/343757a0
28
GengY.YehK.TakataniT.KingM. R. (2012). Three to tango: MUC1 as a ligand for both E-selectin and ICAM-1 in the breast cancer metastatic cascade.Front. Oncol.2:76. 10.3389/fonc.2012.00076
29
Granados-PrincipalS.LiuY.GuevaraM. L.BlancoE.ChoiD. S.QianW.et al (2015). Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.Breast Cancer Res.171–16. 10.1186/s13058-015-0527-x
30
GrattonJ. P.LinM. I.YuJ.WeissE. D.JiangZ. L.FairchildT. A.et al (2003). Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.Cancer Cell431–39. 10.1016/S1535-6108(03)00168-5
31
GreenwoodJ.AmosC. L.WaltersC. E.CouraudP.-O.LyckR.EngelhardtB.et al (2003). Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration.J. Immunol.1712099–2108. 10.4049/jimmunol.171.4.2099
32
GuequénA.CarrascoR.ZamoranoP.RebolledoL.BurboaP.SarmientoJ.et al (2016). S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.Am. J. Physiol. Heart Circ. Physiol.310H1039–H1044. 10.1152/ajpheart.00063.2016
33
HaydenM. S.GhoshS. (2008). Shared Principles in NF-κB Signaling.Cell132344–362. 10.1016/j.cell.2008.01.020
34
HaysE.BonavidaB. (2019). Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies.Antioxidants81–23. 10.3390/antiox8090407
35
HeineckeJ. L.RidnourL. A.ChengR. Y. S.SwitzerC. H.LizardoM. M.KhannaC.et al (2014). Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.Proc. Natl. Acad. Sci. U.S.A.1116323–6328. 10.1073/pnas.1401799111
36
HeoS. K.YunH. J.NohE. K.ParkW. H.ParkS. D. (2008). LPS induces inflammatory responses in human aortic vascular smooth muscle cells via Toll-like receptor 4 expression and nitric oxide production.Immunol. Lett.12057–64. 10.1016/j.imlet.2008.07.002
37
HickeyM. J.GrangerD. N.KubesP. (2001). Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice.Acta Physiol. Scand.173119–126. 10.1046/j.1365-201X.2001.00892.x
38
HolotiukV. V.KryzhanivskaA. Y.ChurpiyI. K.TatarynB. B.IvasiutynD. Y. (2019). Role of nitric oxide in pathogenesis of tumor growth and its possible application in cancer treatment.Exp. Oncol.41210–215. 10.32471/exp-oncology.2312-8852.vol-41-no-3.13515
39
HuangY.ManH.Sekine-aizawaY.HanY.JuluriK.LuoH.et al (2005). S-Nitrosylation of N-Ethylmaleimide Sensitive Factor Mediates Surface Expression of AMPA Receptors.Neuron46533–540. 10.1016/j.neuron.2005.03.028
40
IademarcoM. F.McQuillanJ. J.RosenG. D.DeanD. C. (1992). Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).J. Biol. Chem.26716323–16329.
41
IwakiriY.SatohA.ChatterjeeS.ToomreD. K.ChalouniC. M.FultonD.et al (2006). Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking.Proc. Natl. Acad. Sci. U.S.A.10319777–19782. 10.1073/pnas.0605907103
42
JavaidK.RahmanA.AnwarK. N.FreyR. S.MinshallR. D.MalikA. B. (2003). Tumor necrosis factor-α induces early-onset endothelial adhesivity by protein kinase cζ-dependent activation of intercellular adhesion molecule-1.Circ. Res.921089–1097. 10.1161/01.RES.0000072971.88704.CB
43
JiangM. Z.TsukaharaH.HayakawaK.TodorokiY.TamuraS.OhshimaY.et al (2005). Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells.Respir. Med.99580–591. 10.1016/j.rmed.2004.10.007
44
JohnsonG.TsaoP.LeferA. M. (1990). Synergism between superoxide dismutase and sodium nitrite in cardioprotection following ischemia and reperfusion.Am. Heart J.119530–537. 10.1016/S0002-8703(05)80275-3
45
JoussenA. M.PoulakiV.QinW.KirchhofB.MitsiadesN.WiegandS. J.et al (2002). Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.Am. J. Pathol.160501–509. 10.1016/S0002-9440(10)64869-9
46
KangF.ZhuJ.WuJ.LvT.XiangH.TianJ.et al (2018). O 2-3-Aminopropyl diazeniumdiolates suppress the progression of highly metastatic triple-negative breast cancer by inhibition of microvesicle formation via nitric oxide-based epigenetic regulation.Chem. Sci.96893–6898. 10.1039/c8sc00167g
47
KelleherZ. T.MatsumotoA.StamlerJ. S.MarshallH. E. (2007). NOS2 regulation of NF-κB by S-nitrosylation of p65.J. Biol. Chem.28230667–30672. 10.1074/jbc.M705929200
48
KelleherZ. T.PottsE. N.BrahmajothiM. V.FosterM. W.AutenR. L.Michael FosterW.et al (2011). NOS2 regulation of LPS-induced airway inflammation via S-nitrosylation of NF-κB p65.Am. J. Physiol. Lung Cell. Mol. Physiol301L327–L333. 10.1152/ajplung.00463.2010
49
KelleherZ. T.ShaY.FosterM. W.FosterW. M.ForresterM. T.MarshallH. E. (2014). Thioredoxin-mediated denitrosylation regulates cytokine-induced nuclear factor κB (NF-κB) activation.J. Biol. Chem.2893066–3072. 10.1074/jbc.M113.503938
50
KhanB. V.HarrisonD. G.OlbrychM. T.AlexanderR. W.MedfordR. M. (1996). Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells.Proc. Natl. Acad. Sci. U.S.A.939114–9119. 10.1073/pnas.93.17.9114
51
KhanB. V.ParthasarathyS. S.AlexanderR. W.MedfordR. M. (1995). Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.J. Clin. Invest.951262–1270. 10.1172/JCI117776
52
KijA.KusK.SmedaM.ZakrzewskaA.ProniewskiB.MatyjaszczykK.et al (2018). Differential effects of nitric oxide deficiency on primary tumour growth, pulmonary metastasis and prostacyclin/thromboxane A2 balance in orthotopic and intravenous murine models of 4T1 breast cancer.J. Physiol. Pharmacol.69911–919. 10.26402/jpp.2018.6.05
53
KikkawaU.OgitaK.OnoY.AsaokaY.ShearmanM. S.FujiiT.et al (1987). The common structure and activities of four subspecies of rat brain protein kinase C family.FEBS Lett.223212–216. 10.1016/0014-5793(87)80291-0
54
KongL.DunnG. D.KeeferL. K.KorthuisR. J. (1996). Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules.Clin. Exp. Metastasis14335–343. 10.1007/BF00123392
55
KoriyamaY.FurukawaA. (2018). S-Nitrosylation regulates cell survival and death in the central nervous system.Neurochem. Res.4341–49. 10.1007/s11064-017-2303-z
56
KreugerJ.PhillipsonM. (2016). Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.Nat. Rev. Drug Discov.15125–142. 10.1038/nrd.2015.2
57
KubesP.GrangerD. N. (1992). Nitric oxide modulates microvascular permeability.Am. J. Physiol. Hear. Circ. Physiol.262H611–H615. 10.1152/ajpheart.1992.262.2.h611
58
KubesP.SuzukiM.GrangerD. N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion.Proc. Natl. Acad. Sci. U.S.A.884651–4655. 10.1073/pnas.88.11.4651
59
LarsenG. R.SakoD.AhernT. J.ShafferM.ErbanJ.SajerS. A.et al (1992). P-selectin and E-selectin distinct but overlapping leukocyte ligand specificities.J. Biol. Chemestry26711104–11110.
60
LedeburH. C.ParksT. P. (1995). Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells.J. Biol. Chem.270933–943. 10.1074/jbc.270.2.933
61
LeeJ.ReichR.XuF.SehgalP. B. (2009). Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.Am. J. Physiol. Lung Cell. Mol. Physiol297L715–L728. 10.1152/ajplung.00086.2009
62
LeeS. K.KimJ. H.YangW. S.KimS. B.ParkS. K.ParkJ. S. (2002). Exogenous nitric oxide inhibits VCAM-1 expression in human peritoneal mesothelial cells: role of cyclic GMP and NF-κB.Nephron90447–454. 10.1159/000054733
63
LeferD. J.JonesS. P.GirodW. G.BainesA.GrishamM. B.CockrellA. S.et al (1999). Leukocyte-endothelial cell interactions in nitric oxide synthase- deficient mice.Am. J. Physiol. Hear. Circ. Physiol.2761943–1950. 10.1152/ajpheart.1999.276.6.h1943
64
LeickM.AzcutiaV.NewtonG.LuscinskasF. W. (2014). Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies.Cell Tissue Res.355647–656. 10.1007/s00441-014-1809-9
65
LelamaliK.WangW.GengaroP.EdelsteinC.SchrierR. W. (2001). Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium.J. Cell. Physiol.188337–342. 10.1002/jcp.1128
66
LeyK.LaudannaC.CybulskyM. I.NoursharghS. (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated.Nat. Rev. Immunol.7678–689. 10.1038/nri2156
67
LiF.SonveauxP.RabbaniZ. N.LiuS.YanB.HuangQ.et al (2007). Regulation of HIF-1α Stability through S-Nitrosylation.Mol. Cell2663–74. 10.1016/j.molcel.2007.02.024
68
LiuG.VogelS. M.GaoX.JavaidK.HuG.DanilovS. M.et al (2011). Src phosphorylation of endothelial cell surface intercellular adhesion molecule-1 mediates neutrophil adhesion and contributes to the mechanism of lung inflammation.Arterioscler. Thromb. Vasc. Biol.311342–1350. 10.1161/ATVBAHA.110.222208
69
LiuP.XuB.HockC. E.NageleR.SunF. F.WongP. Y. K. (1998). No modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R.Am. J. Physiol. Hear. Circ. Physiol.2752191–2198. 10.1152/ajpheart.1998.275.6.h2191
70
LoH. P.Ackland-BerglundC. E.PritchardK. A.GuiceK. S.OldhamK. T. (2001). Attenuated expression of inducible nitric oxide synthase in lung microvascular endothelial cells is associated with an increase in ICAM-1 expression.J. Pediatr. Surg.361136–1142. 10.1053/jpsu.2001.25731
71
López-SánchezL. M.ArandaE.Rodríguez-ArizaA. (2019). Nitric oxide and tumor metabolic reprogramming.Biochem. Pharmacol.176:113769. 10.1016/j.bcp.2019.113769
72
LowensteinC. J. (2007). Nitric oxide regulation of protein trafficking in the cardiovascular system.Cardiovasc. Res.75240–246. 10.1016/j.cardiores.2007.03.024
73
LuY.YuT.LiangH.WangJ.XieJ.ShaoJ.et al (2014). Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade.Sci. Rep.41–9. 10.1038/srep04344
74
MaX. I.WeyrichA. S.LeferD. J.LeferA. M. (1993). Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.Circ. Res.72403–412. 10.1161/01.res.72.2.403
75
MacKesyD. Z.GoalstoneM. L. (2011). Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells.J. Inflamm.8:34. 10.1186/1476-9255-8-34
76
MarínN.ZamoranoP.CarrascoR.MujicaP.GonzálezF. G.QuezadaC.et al (2012). S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.Circ. Res.111553–563. 10.1161/CIRCRESAHA.112.274548
77
MarshallH. E.StamlerJ. S. (2001). Inhibition of NF-κB by S-nitrosylation.Biochemistry401688–1693. 10.1021/bi002239y
78
MatsushitaK.MorrellC. N.CambienB.YangS. X.YamakuchiM.BaoC.et al (2003). Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor.Cell115139–150. 10.1016/S0092-8674(03)00803-1
79
MatthewsJ. R.BottingC. H.PanicoM.MorrisH. R.HayR. T. (1996). Inhibition of NF-kappaB DNA binding by nitric oxide.Nucl. Acids Res 15242236–2242. 10.1093/nar/24.12.2236
80
McCruddenC. M.McBrideJ. W.McCaffreyJ.AliA. A.DunneN. J.KettV. L.et al (2017). Systemic RALA/iNOS nanoparticles: a potent gene therapy for metastatic breast cancer coupled as a biomarker of treatment.Mol. Ther. Nucleic Acids6249–258. 10.1016/j.omtn.2016.12.010
81
McDowellS. A. C.QuailD. F. (2019). Immunological regulation of vascular inflammation during cancer metastasis.Front. Immunol.10:1984. 10.3389/fimmu.2019.01984
82
MeffertM. K.CalakosN. C.SchellerR. H.SchulmanH. (1996). Nitric oxide modulates synaptic vesicle docking/fusion reactions.Neuron161229–1236. 10.1016/S0896-6273(00)80149-X
83
MetcalfD. J.NightingaleT. D.ZennerH. L.Lui-RobertsW. W.CutlerD. F. (2008). Formation and function of Weibel-Palade bodies.J. Cell Sci.12119–27. 10.1242/jcs.03494
84
MitchellD. J.YuJ.TymlK. (1998). Local l-NAME decreases blood flow and increases leukocyte adhesion via CD18.Am. J. Physiol.274H1264–H1268. 10.1152/ajpheart.1998.274.4.H1264
85
MonteiroH.CostaP.ReisA.SternA. (2015). Nitric oxide: protein tyrosine phosphorylation and protein S-nitrosylation in cancer.Biomed. J.38380–388. 10.4103/2319-4170.158624
86
MorganA.BurgoyneR. D. (2004). Membrane traffic: controlling membrane fusion by modifying NSF.Curr. Biol.14968–970. 10.1016/j.cub.2004.10.045
87
MukhopadhyayS.LeeJ.SehgalP. B. (2008). Depletion of the ATPase NSF from Golgi membranes with hypo-S-nitrosylation of vasorelevant proteins in endothelial cells exposed to monocrotaline pyrrole.Am. J. Physiol. Hear. Circ. Physiol.2951–30. 10.1152/ajpheart.00642.2008
88
MüllerA.HomeyB.SotoH.GeN.CatronD.BuchananM. E.et al (2001). Involvement of chemokine receptors in breast cancer metastasis.Nature41050–56. 10.1038/35065016
89
MussbacherM.SalzmannM.BrostjanC.HoeselB.SchoergenhoferC.DatlerH.et al (2019). Cell type specific roles of nf-kb linking inflamation and thrombosis.Front. Immunol.10:85. 10.3389/fimmu.2019.00085
90
NagyG.ClarkJ. M.BuzásE. I.GormanC. L.CopeA. P. (2007). Nitric oxide, chronic inflammation and autoimmunity.Immunol. Lett.1111–5. 10.1016/j.imlet.2007.04.013
91
PanJ.McEverR. P. (1995). Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family.J. Biol. Chem.27023077–23083. 10.1074/jbc.270.39.23077
92
PierceJ. W.SchoenleberR.JesmokG.BestJ.MooreS. A.CollinsT.et al (1997). Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.J. Biol. Chem.27221096–21103. 10.1074/jbc.272.34.21096
93
QianJ.FultonD. J. R. (2012). Exogenous, but not endogenous nitric oxide inhibits adhesion molecule expression in human endothelial cells.Front. Physiol.3:3. 10.3389/fphys.2012.00003
94
RadisavljevicZ.AvrahamH.AvrahamS. (2000). Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells.J. Biol. Chem.27520770–20774. 10.1074/jbc.M002448200
95
RahmanM. A.SengaT.ItoS.HyodoT.HasegawaH.HamaguchiM. (2010). S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion.J. Biol. Chem.2853806–3814. 10.1074/jbc.M109.059782
96
RahnJ. J.ChowJ. W.HorneG. J.MahB. K.EmermanJ. T.HoffmanP.et al (2005). MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.Clin. Exp. Metastasis22475–483. 10.1007/s10585-005-3098-x
97
RandriamboavonjyV.SchraderJ.BusseR.FlemingI. (2004). Insulin induces the release of vasodilator compounds from platelets by a nitric oxide-G Kinase-VAMP-3-dependent pathway.J. Exp. Med.199347–356. 10.1084/jem.20030694
98
ReymondN.D’ÁguaB. B.RidleyA. J. (2013). Crossing the endothelial barrier during metastasis.Nat. Rev. Cancer13858–870. 10.1038/nrc3628
99
ReynaertN. L.CklessK.KornS. H.VosN.GualaA. S.WoutersE. F. M.et al (2004). Nitric oxide represses inhibitory κB kinase through S-nitrosylation.Proc. Natl. Acad. Sci. U.S.A.1018945–8950. 10.1073/pnas.0400588101
100
RidnourL. A.ThomasD. D.DonzelliS.EspeyM. G.RobertsD. D.WinkD. A.et al (2006). The biphasic nature of nitric oxide responses in tumor biology.Antioxidants Redox Signal.81329–1337. 10.1089/ars.2006.8.1329
101
RizzaS.FilomeniG. (2018). Role, targets and regulation of (de)nitrosylation in malignancy.Front. Oncol.8:334. 10.3389/fonc.2018.00334
102
RomagnyS.BouaouicheS.LucchiG.DucoroyP.BertoldoJ. B.TerenziH.et al (2018). S-Nitrosylation of cIAP1 switches cancer cell fate from TNFα/TNFR1-mediated cell survival to cell death.Cancer Res.781948–1957. 10.1158/0008-5472.CAN-17-2078
103
SánchezF. A.RanaR.GonzálezF. G.IwahashiT.DuránR. G.FultonD. J.et al (2011). Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.J. Biol. Chem.28630409–30414. 10.1074/jbc.M111.234294
104
SánchezF. A.SavaliaN. B.DuránR. G.LalB. K.BoricM. P.DuránW. N. (2006). Functional significance of differential eNOS translocation.Am. J. Physiol. Hear. Circ. Physiol.291H1058–H1064. 10.1152/ajpheart.00370.2006
105
ScherR. L. (2007). Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.Laryngoscope117199–209. 10.1097/MLG.0b013e31802c6e83
106
SektiogluI. M.CarreteroR.BenderN.BogdanC.GarbiN.UmanskyV.et al (2016). Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection.Oncoimmunology5:e1204506. 10.1080/2162402X.2016.1204506
107
SetiadiH.McEverR. P. (2008). Clustering endothelial E-selectin in clathrin-coated pits and lipid rafts enhances leukocyte adhesion under flow.Blood1111989–1998. 10.1182/blood-2007-09-113423
108
SetiadiH.SedgewickG.ErlandsenS. L.McEverR. P. (1998). Interactions of the cytoplasmic domain of P-selectin with clathrin- coated pits enhance leukocyte adhesion under flow.J. Cell Biol.142859–871. 10.1083/jcb.142.3.859
109
ShaY.MarshallH. E. (2012). S-nitrosylation in the regulation of gene transcription.Biochim. Biophys. Acta Gen. Subj.1820701–711. 10.1016/j.bbagen.2011.05.008
110
SheltonJ. L.WangL.CepinskasG.InculetR.MehtaS. (2008). Human neutrophil-pulmonary microvascular endothelial cell interactions in vitro: differential effects of nitric oxide vs. peroxynitrite.Microvasc. Res.7680–88. 10.1016/j.mvr.2008.06.001
111
ShirureV. S.LiuT.DelgadilloL. F.CucklerC. M.TeesD. F. J.BenenciaF.et al (2015). CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.Am. J. Physiol. Cell Physiol.308C68–C78. 10.1152/ajpcell.00094.2014
112
SökelandG.SchumacherU. (2019). The functional role of integrins during intra- and extravasation within the metastatic cascade.Mol. Cancer18:12. 10.1186/s12943-018-0937-3
113
SöllnerT.WhiteheartS. W.BrunnerM.Erdjument-BromageH.GeromanosS.TempstP.et al (1993). SNAP receptors implicated in vesicle targeting and fusion.Nature362318–324. 10.1038/362318a0
114
SomasundaramV.BasudharD.BharadwajG.NoJ. H.RidnourL. A.ChengR. Y. S.et al (2019). Molecular mechanisms of nitric oxide in cancer progression, signal transduction, and metabolism.Antioxidants Redox Signal.301124–1143. 10.1089/ars.2018.7527
115
SperandioM. (2006). Selectins and glycosyltransferases in leukocyte rolling in vivo.FEBS J.2734377–4389. 10.1111/j.1742-4658.2006.05437.x
116
SpringerT. A. (1990). Adhesion receptors of the immune system.Nature346425–434. 10.1038/346425a0
117
StamlerJ. S.SimonD. I.OsborneJ. A.MullinsM. E.JarakiO.MichelT.et al (1992). S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.Proc. Natl. Acad. Sci. U.S.A.89444–448. 10.1073/pnas.89.1.444
118
StojakM.KaczaraP.MotterliniR.ChlopickiS. (2018). Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells.Pharmacol. Res.136160–171. 10.1016/j.phrs.2018.09.005
119
StrellC.EntschladenF. (2008). Extravasation of leukocytes in comparison to tumor cells.Cell Commun. Signal.6:10. 10.1186/1478-811X-6-10
120
StrilicB.OffermannsS. (2017). Intravascular survival and extravasation of tumor cells.Cancer Cell32282–293. 10.1016/j.ccell.2017.07.001
121
SugamaY.TiruppathiC.JanakideviK.AndersenT. T.FentonJ. W.MalikA. B. (1992). Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion.J. Cell Biol.119935–944. 10.1083/jcb.119.4.935
122
TalmadgeJ. E. (2010). Models of metastasis in drug discovery.Methods Mol. Biol.602215–233. 10.1007/978-1-60761-058-8_13
123
ThanosD.ManiatisT. (1995). NF-κB: a lesson in family values.Cell80529–532. 10.1016/0092-8674(95)90506-5
124
ThomS. R.BhopaleV. M.MilovanovaT. N.YangM.BogushM.BuerkR. G. (2013). Nitric-oxide Synthase-2 linkage to focal adhesion kinase in neutrophils influences enzyme activity and β2 integrin function.J. Biol. Chem.2884810–4818. 10.1074/jbc.M112.426353
125
ThomasD. D.WinkD. A. (2017). NOS2 as an emergent player in progression of cancer.Antioxidants Redox Signal.26963–965. 10.1089/ars.2016.6835
126
TichetM.ProdhommeV.FenouilleN.AmbrosettiD.MallavialleA.CerezoM.et al (2015). Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis.Nat. Commun.6:6993. 10.1038/ncomms7993
127
TilghmanR. W.HooverR. L. (2002a). E-selectin and ICAM-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells.FEBS Lett.52583–87. 10.1016/S0014-5793(02)03070-3
128
TilghmanR. W.HooverR. L. (2002b). The Src-cortactin pathway is required for clustering of E-selectin and ICAM-1 in endothelial cells.FASEB J.161257–1259. 10.1096/fj.01-0969fje
129
TsaoP. S.McEvoyL. M.DrexlerH.ButcherE. C.CookeJ. P. (1994). Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.Circulation892176–2182. 10.1161/01.CIR.89.5.2176
130
TutejaN.ChandraM.TutejaR.MisraM. K. (2004). Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology.J. Biomed. Biotechnol.2004227–237. 10.1155/S1110724304402034
131
TvaroškaI.SelvarajC.KoèaJ. (2020). Selectins-The two Dr. Jekyll and Mr. Hyde faces of adhesion molecules-A review.Molecules252835. 10.3390/molecules25122835
132
UmanskyV.HehnerS. P.DumontA.HofmannT. G.SchirrmacherV.DrögeW.et al (1998). Co-stimulatory effect of nitric oxide on endothelial NF-κB implies a physiological self-amplifying mechanism.Eur. J. Immunol.282276–2282. 10.1002/(sici)1521-4141(199808)28:08<2276::aid-immu2276>3.0.co;2-h
133
VallanceB. A.DijkstraG.QiuB.Van Der WaaijL. A.Van GoorH.JansenP. L. M.et al (2004). Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity.Am. J. Physiol. Gastrointest. Liver Physiol.287G865–G874. 10.1152/ajpgi.00187.2004
134
Van De StolpeA.CaldenhovenE.StadeG.KoendermanL.RaaijmakersJ. A.JohnsonJ. P. (1994). 12-O-Tetradecanoylphorbol-13-acetatand tumor necrosis factor of intercellular adhesion molecule-1 is a-mediated induction inhibited by dexamethasone.J. Biol. Chem.2696185–6192. 10.1016/s0168-8278(96)80237-6
135
VaniniF.KashfiK.NathN. (2015). The dual role of iNOS in cancer.Redox Biol.6334–343. 10.1016/j.redox.2015.08.009
136
VidalM. J.ZocchiM. R.PoggiA.PellegattaF.ChierchiaS. L. (1992). Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells.J. Cardiovascul. Pharmacol.20(Suppl. 12), S155-S159. 10.1097/00005344-199204002-00044
137
WaldowT.WittW.WeberE.MatschkeK. (2006). Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFκB activation in endothelial cells.Nitric Oxide Biol. Chem.15103–113. 10.1016/j.niox.2005.12.005
138
WangB.XiongQ.ShiQ.TanD.LeX.XieK. (2001). Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion.Int. J. Cancer91607–611. 10.1002/1097-0215(200002)9999:9999<::aid-ijc1109>3.0.co;2-d
139
WangX.ZalcensteinA.OrenM. (2003). Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation.Cell Death Differ.10468–476. 10.1038/sj.cdd.4401181
140
WangY.LiuT.WuC.LiH. (2008). A strategy for direct identification of protein S-nitrosylation sites by quadrupole time-of-flight mass spectrometry.J. Am. Soc. Mass Spectrom.191353–1360. 10.1016/j.jasms.2008.06.001
141
WeibelE. R.PaladeG. E. (1964). NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.J. Cell Biol.23101–112. 10.1083/jcb.23.1.101
142
WhelanJ.GhersaP.Van HuijsduijnenR. H.GrayJ.ChandraG.TalabotF.et al (1991). An NFxB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription.Nucl. Acids Res.192645–2653. 10.1093/nar/19.10.2645
143
WolfM. J.HoosA.BauerJ.BoettcherS.KnustM.WeberA.et al (2012). Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway.Cancer Cell2291–105. 10.1016/j.ccr.2012.05.023
144
XiaY. F.LiuL. P.ZhongC. P.GengJ. G. (2001). Nf-κB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells.Biochem. Biophys. Res. Commun.289851–856. 10.1006/bbrc.2001.6067
145
XuS.ZhouX.YuanD.XuY.HeP. (2013). Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules.Am. J. Physiol. Hear. Circ. Physiol305H1484–H1493. 10.1152/ajpheart.00382.2013
146
YudohK.MatsuiH.TsujiH. (1997). Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro.Clin. Exp. Metastasis15557–567. 10.1023/A:1018487213157
147
ZamoranoP.KoningT.OyanadelC.MardonesG. A.EhrenfeldP.BoricM. P.et al (2019). Galectin-8 induces endothelial hyperpermeability through the eNOS pathway involving S-nitrosylation-mediated adherens junction disassembly.Carcinogenesis40313–323. 10.1093/carcin/bgz002
148
ZhangH.WongC. C. L.WeiH.GilkesD. M.KorangathP.ChaturvediP.et al (2012). HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.Oncogene311757–1770. 10.1038/onc.2011.365
149
ZhangL.ZengM.FuB. M. (2016). Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.Am. J. Physiol. Hear. Circ. Physiol.310H1735–H1747. 10.1152/ajpheart.00109.2016
150
ZhangQ.ChurchJ. E.JagnandanD.CatravasJ. D.SessaW. C.FultonD. (2006). Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells.Arterioscler. Thromb. Vasc. Biol.261015–1021. 10.1161/01.ATV.0000216044.49494.c4
Summary
Keywords
nitric oxide, S-nitrosylation, leukocyte adhesion, tumor cell adhesion, inflammation
Citation
Aguilar G, Koning T, Ehrenfeld P and Sánchez FA (2020) Role of NO and S-nitrosylation in the Expression of Endothelial Adhesion Proteins That Regulate Leukocyte and Tumor Cell Adhesion. Front. Physiol. 11:595526. doi: 10.3389/fphys.2020.595526
Received
16 August 2020
Accepted
20 October 2020
Published
13 November 2020
Volume
11 - 2020
Edited by
Xavier Figueroa, Pontificia Universidad Católica de Chile, Chile
Reviewed by
Nicola Conran, Campinas State University, Brazil; Carlos Cabañas, Consejo Superior de Investigaciones Científicas (CSIC), Spain
Updates
Copyright
© 2020 Aguilar, Koning, Ehrenfeld and Sánchez.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pamela Ehrenfeld, ingridehrenfeld@uach.cl; pamelaehrenfeld74@gmail.comFabiola A. Sánchez, fabiolasanchez@uach.cl
†These authors share first authorship
This article was submitted to Vascular Physiology, a section of the journal Frontiers in Physiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.